Description
An ACK1/TNK2 inhibitor (IC50 = 21.58 nM); selective for ACK1/TNK2 over Abl1, BTK, LCK, and LYN (IC50s = 705.9, 871.7, 432.3, and 346.7 nM, respectively), as well as a panel of 25 additional kinases; inhibits EGF-induced increases in ATM protein levels, ACK1/TNK2 and androgen receptor phosphorylation, and pTyr267-androgen receptor binding to the ATM enhancer in LAPC4 cells at 1 μM; inhibits the growth of LNCaP and LAPC4 cells in a concentration-dependent manner and induces cell cycle arrest at the G0/G1 phase at 3 μM; enhances radiation-induced tumor growth reduction in an LNCaP-caAck CRPC mouse xenograft model at 4 mg/kg
Formal name: 5,6-diphenyl-N-[[(2S)-tetrahydro-2-furanyl]methyl]-furo[2,3-d]pyrimidin-4-amine
Synonyms:
Molecular weight: 371.4
CAS: 873305-35-2
Purity: ≥98%
Formulation: A crystalline solid